Should the hematocrit (hemoglobin) be normalized in Pre-ESRD or dialysis patients? Yes!
Besarab
A
A
Section of Nephrology, Department of Medicine, West Virginia University School of Medicine, Morgantown, WV 26506, USA. abesarab@hsc.wvu.edu
Aslam
M
M
D000222:Adaptation, Physiological; D000740:Anemia / Q000191:economics / Q000209:etiology / Q000517:prevention & control*; D002319:Cardiovascular System / Q000503:physiopathology; D003072:Cognition Disorders / Q000209:etiology / Q000517:prevention & control; D016527:Drug Costs; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D015444:Exercise / Q000502:physiology; D006333:Heart Failure / Q000209:etiology / Q000517:prevention & control; D006400:Hematocrit; D006439:Hemodynamics; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000209:etiology / Q000517:prevention & control; D007501:Iron / Q000191:economics / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000150:complications / Q000191:economics / Q000628:therapy; D015337:Multicenter Studies as Topic; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D012016:Reference Values; D006435:Renal Dialysis; D012306:Risk; D019851:Thrombophilia / Q000139:chemically induced; D016896:Treatment Outcome
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa; D007501:Iron